{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T21:59:54Z","timestamp":1759960794567},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T00:00:00Z","timestamp":1384560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00253-013-5351-6","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T07:48:43Z","timestamp":1384501723000},"page":"1547-1555","source":"Crossref","is-referenced-by-count":9,"title":["Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein"],"prefix":"10.1007","volume":"98","author":[{"given":"Ruosen","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hualong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongge","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,16]]},"reference":[{"key":"5351_CR1","first-page":"217","volume":"4","author":"F Andr\u00e9","year":"2013","unstructured":"Andr\u00e9 F, Michael H, Thomas S (2013) Expression of recombinant antibodies. Front Immunol 4:217. doi: 10.3389\/fimmu.2013.00217","journal-title":"Front Immunol"},{"issue":"4","key":"5351_CR2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10555-005-6193-1","volume":"24","author":"M Arbabi-Ghahroudi","year":"2005","unstructured":"Arbabi-Ghahroudi M, Tanha J, MacKenzie R (2005) Prokaryotic expression of antibodies. Cancer Metastasis Rev 24(4):501\u2013519. doi: 10.1007\/s10555-005-6193-1","journal-title":"Cancer Metastasis Rev"},{"issue":"14","key":"5351_CR3","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","volume":"79","author":"ABH Bakker","year":"2005","unstructured":"Bakker ABH, Marissen WE, Kramer RA, Rice AB, Weldon WC, Niezgoda M, Hanlon CA, Thijsse S, Backus HHJ, De Kruif J (2005) Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J Virol 79(14):9062\u20139068. doi: 10.1128\/JVI.79.14.9062-9068.2005","journal-title":"J Virol"},{"issue":"1\u20132","key":"5351_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","volume":"100","author":"JD Beatty","year":"1987","unstructured":"Beatty JD, Beatty BG, Vlahos WG (1987) Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 100(1\u20132):173\u2013179","journal-title":"J Immunol Methods"},{"issue":"4877","key":"5351_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.3140379","volume":"242","author":"RE Bird","year":"1988","unstructured":"Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS, Whitlow M (1988) Single-chain antigen-binding proteins. Science 242(4877):423\u2013426. doi: 10.1126\/science.3140379 , New York, NY","journal-title":"Science"},{"issue":"11","key":"5351_CR6","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1371\/journal.pntd.0000839","volume":"4","author":"H Bourhy","year":"2010","unstructured":"Bourhy H, Dautry-Varsat A, Hotez PJ, Salomon J (2010) Rabies, still neglected after 125\u00a0years of vaccination. PLoS Negl Trop Dis 4(11):e839. doi: 10.1371\/journal.pntd.0000839","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"5351_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-70-2-291","volume":"70","author":"H Bunschoten","year":"1989","unstructured":"Bunschoten H, Gore M, Ivo JTM, Uytdehaag FGCM, Dietzschold B, Wunner WH, Osterhaus ADME (1989) Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J Gen Virol 70(2):291\u2013298. doi: 10.1099\/0022-1317-70-2-291","journal-title":"J Gen Virol"},{"issue":"1","key":"5351_CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","volume":"212","author":"F Cliquet","year":"1998","unstructured":"Cliquet F, Aubert M, Sagne L (1998) Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods 212(1):79\u201387","journal-title":"J Immunol Methods"},{"issue":"28","key":"5351_CR9","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/S0264-410X(00)00127-4","volume":"18","author":"F Cliquet","year":"2000","unstructured":"Cliquet F, Sagne L, Schereffer J, Aubert M (2000) ELISA test for rabies antibody titration in orally vaccinated foxes sampled in the fields. Vaccine 18(28):3272\u20133279. doi: 10.1016\/S0264-410X(00)00127-4","journal-title":"Vaccine"},{"issue":"1","key":"5351_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1099\/0022-1317-61-1-97","volume":"61","author":"P Coulon","year":"1982","unstructured":"Coulon P, Rollin P, Aubert M, Flamand A (1982) Molecular basis of rabies virus virulence. I. Selection of avirulent mutants of the CVS strain with anti-G monoclonal antibodies. J Gen Virol 61(1):97\u2013100. doi: 10.1099\/0022-1317-61-1-97","journal-title":"J Gen Virol"},{"issue":"3","key":"5351_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biotechadv.2009.01.008","volume":"27","author":"AL Demain","year":"2009","unstructured":"Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27(3):297\u2013306. doi: 10.1016\/j.biotechadv.2009.01.008","journal-title":"Biotechnol Adv"},{"issue":"2","key":"5351_CR12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.molimm.2012.03.015","volume":"51","author":"Y Duan","year":"2012","unstructured":"Duan Y, Gu T, Jiang C, Yuan R, Zhang H, Hou H, Yu X, Chen Y, Zhang Y, Wu Y (2012) A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency. Mol Immunol 51(2):188\u2013196. doi: 10.1016\/j.molimm.2012.03.015","journal-title":"Mol Immunol"},{"issue":"12","key":"5351_CR13","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","volume":"25","author":"M Feyssaguet","year":"2007","unstructured":"Feyssaguet M, Dacheux L, Audry L, Compoint A, Morize J, Blanchard I, Bourhy H (2007) Multicenter comparative study of a new ELISA, PLATELIA\u2122 RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people. Vaccine 25(12):2244\u20132251. doi: 10.1016\/j.vaccine.2006.12.012","journal-title":"Vaccine"},{"issue":"11","key":"5351_CR14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2174\/092986611797200995","volume":"18","author":"T Gu","year":"2011","unstructured":"Gu T, Wei W, Duan Y, Jiang C, Chen Y, Yu X, Wu J, Wu Y, Kong W (2011) Identification of binding epitope for anti-rabies virus glycoprotein single-chain Fv fragment FV57. Protein Pept Lett 18(11):1099\u20131106","journal-title":"Protein Pept Lett"},{"issue":"28","key":"5351_CR15","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","volume":"19","author":"C Hanlon","year":"2001","unstructured":"Hanlon C, DeMattos C, DeMattos C, Niezgoda M, Hooper D, Koprowski H, Notkins A, Rupprecht C (2001) Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis. Vaccine 19(28):3834\u20133842. doi: 10.1016\/S0264-410X(01)00135-9","journal-title":"Vaccine"},{"issue":"2","key":"5351_CR16","first-page":"172","volume":"4","author":"D Humphreys","year":"2001","unstructured":"Humphreys D, Glover D (2001) Therapeutic antibody production technologies: molecules, applications, expression and purification. Curr Opin Drug Discov Dev 4(2):172\u2013185","journal-title":"Curr Opin Drug Discov Dev"},{"key":"5351_CR17","doi-asserted-by":"crossref","unstructured":"Jiang H, Xie Y, Burnette A, Roach J, Giardina SL, Hecht TT, Creekmore SP, Mitra G, Zhu J (2013) Purification of clinical-grade disulfide stabilized antibody fragment variable\u2014Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli. Appl Microbiol Biotechnol:621\u2013632. doi: 10.1007\/s00253-012-4319-2","DOI":"10.1007\/s00253-012-4319-2"},{"issue":"5","key":"5351_CR18","first-page":"360","volume":"83","author":"DL Knobel","year":"2005","unstructured":"Knobel DL, Cleaveland S, Coleman PG, F\u00e8vre EM, Meltzer MI, Miranda MEG, Shaw A, Zinsstag J, Meslin FX (2005) Re-evaluating the burden of rabies in Africa and Asia. B World Health Organ 83(5):360\u2013368. doi: 10.1590\/S0042-96862005000500012","journal-title":"B World Health Organ"},{"issue":"7","key":"5351_CR19","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/eji.200526134","volume":"35","author":"RA Kramer","year":"2005","unstructured":"Kramer RA, Marissen WE, Goudsmit J, Visser TJ, Clijsters-Van der Horst M, Bakker AQ, de Jong M, Jongeneelen M, Thijsse S, Backus HHJ (2005) The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur J Immunol 35(7):2131\u20132145. doi: 10.1002\/eji.200526134","journal-title":"Eur J Immunol"},{"issue":"5","key":"5351_CR20","doi-asserted-by":"crossref","first-page":"e19848","DOI":"10.1371\/journal.pone.0019848","volume":"6","author":"X Liu","year":"2011","unstructured":"Liu X, Lin H, Tang Q, Li C, Yang S, Wang Z, Wang C, He Q, Cao B, Feng Z (2011) Characterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccine. PLoS One 6(5):e19848. doi: 10.1371\/journal.pone.0019848","journal-title":"PLoS One"},{"issue":"1","key":"5351_CR21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pep.2005.05.013","volume":"44","author":"A Lombardi","year":"2005","unstructured":"Lombardi A, Sperandei M, Cantale C, Giacomini P, Galeffi P (2005) Functional expression of a single-chain antibody specific for the HER2 human oncogene in a bacterial reducing environment. Protein Expr Purif 44(1):10\u201315. doi: 10.1016\/j.pep.2005.05.013","journal-title":"Protein Expr Purif"},{"issue":"2","key":"5351_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(88)90196-2","volume":"106","author":"RA MacDonald","year":"1988","unstructured":"MacDonald RA, Hosking CS, Jones CL (1988) The measurement of relative antibody affinity by ELISA using thiocyanate elution. J Immunol Methods 106(2):191\u2013194. doi: 10.1016\/0022-1759(88)90196-2","journal-title":"J Immunol Methods"},{"issue":"8","key":"5351_CR23","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","volume":"79","author":"WE Marissen","year":"2005","unstructured":"Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ (2005) Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol 79(8):4672\u20134678. doi: 10.1128\/JVI.79.8.4672-4678.2005","journal-title":"J Virol"},{"issue":"3","key":"5351_CR24","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","volume":"4","author":"SM Moore","year":"2010","unstructured":"Moore SM, Hanlon CA (2010) Rabies-specific antibodies: measuring surrogates of protection against a fatal disease. PLoS Negl Trop Dis 4(3):e595. doi: 10.1371\/journal.pntd.0000595","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"5351_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0166-0934(97)00099-2","volume":"67","author":"BH Muller","year":"1997","unstructured":"Muller BH, Lafay F, Demangel C, Perrin P, Tordo N, Flamand A, Lafaye P, Guesdon JL (1997) Phage-displayed and soluble mouse scFv fragments neutralize rabies virus. J Virol Methods 67(2):221\u2013233. doi: 10.1016\/S0166-0934(97)00099-2","journal-title":"J Virol Methods"},{"issue":"9","key":"5351_CR26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1348-0421.1995.tb03258.x","volume":"39","author":"Y Ni","year":"1995","unstructured":"Ni Y, Tominaga Y, Honda Y, Morimoto K, Sakamoto S, Kawai A (1995) Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719. Med Microbiol Immunol 39(9):693","journal-title":"Med Microbiol Immunol"},{"key":"5351_CR27","unstructured":"Ohlfest JR, Zellmer DM, Panyam J, Swaminathan SK, Oh S, Waldron NN, Toma S, Vallera DA (2012) Immunotoxin targeting CD133+ breast carcinoma cells. Drug Deliv and Transl Res: 195\u2013204"},{"issue":"1","key":"5351_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.62.1.1-7.1988","volume":"62","author":"C Prehaud","year":"1988","unstructured":"Prehaud C, Coulon P, Lafay F, Thiers C, Flamand A (1988) Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J Virol 62(1):1\u20137","journal-title":"J Virol"},{"issue":"1","key":"5351_CR29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","volume":"188","author":"M Prosniak","year":"2003","unstructured":"Prosniak M, Faber M, Hanlon CA, Rupprecht CE, Hooper DC, Dietzschold B (2003) Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J Infect Dis 188(1):53\u201356. doi: 10.1086\/375247","journal-title":"J Infect Dis"},{"issue":"3","key":"5351_CR30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Epidemiol 27(3):493\u2013497","journal-title":"Am J Epidemiol"},{"issue":"3","key":"5351_CR31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","volume":"84","author":"CL Schumacher","year":"1989","unstructured":"Schumacher CL, Dietzschold B, Ertl H, Niu HS, Rupprecht CE, Koprowski H (1989) Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest 84(3):971\u2013975. doi: 10.1172\/JCI114260","journal-title":"J Clin Invest"},{"issue":"4","key":"5351_CR32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1263\/jbb.99.303","volume":"99","author":"SM Singh","year":"2005","unstructured":"Singh SM, Panda AK (2005) Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 99(4):303\u2013310. doi: 10.1263\/jbb.99.303","journal-title":"J Biosci Bioeng"},{"issue":"5","key":"5351_CR33","first-page":"535","volume":"48","author":"JS Smith","year":"1973","unstructured":"Smith JS, Yager PA, Baer GM (1973) A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48(5):535\u2013541","journal-title":"Bull World Health Organ"},{"issue":"1","key":"5351_CR34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","volume":"41","author":"FW Studier","year":"2005","unstructured":"Studier FW (2005) Protein production by auto-induction in high-density shaking cultures. Protein Expr Purif 41(1):207\u2013234. doi: 10.1016\/j.pep.2005.01.016","journal-title":"Protein Expr Purif"},{"issue":"4","key":"5351_CR35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00253-009-2379-8","volume":"86","author":"J Yang","year":"2010","unstructured":"Yang J, Chen R, Wei J, Zhang F, Zhang Y, Jia L, Yan Y, Luo W, Cao Y, Yao L (2010) Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein. Appl Microbiol Biotechnol 86(4):1067\u20131075. doi: 10.1007\/s00253-009-2379-8","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-013-5351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-013-5351-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-013-5351-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T01:17:38Z","timestamp":1596849458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-013-5351-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,16]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["5351"],"URL":"https:\/\/doi.org\/10.1007\/s00253-013-5351-6","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,16]]}}}